Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/31/2025

Antibiotic Classification and Clinical Applications

Classification and Structural Relationship

  • The American College of Clinical Microbiology recommends classifying cephalexin as a first-generation cephalosporin, while amoxicillin is classified as an aminopenicillin, and cloxacillin is classified as a penicillinase-resistant penicillin, with different antimicrobial spectrums and clinical applications 1, 2
  • Both cephalosporins and penicillins are beta-lactam antibiotics, but they are distinct classes with different clinical applications, as noted by the Clinical Microbiology and Infection guidelines 1, 6

Clinical Applications and Overlap

  • For mild skin and soft tissue infections, the Diabetes/Metabolism Research and Reviews guidelines recommend cloxacillin and cephalexin as first-line options for gram-positive cocci infections, with a strength of evidence based on clinical trials 3, 4
  • For impetigo, the Clinical Microbiology and Infection guidelines recommend oral dicloxacillin, cephalexin, erythromycin, clindamycin, or amoxicillin-clavulanic acid, with a moderate strength of evidence 1
  • For diabetic foot infections, the Diabetes/Metabolism Research and Reviews guidelines recommend cephalexin and cloxacillin for mild infections caused by gram-positive cocci, with a low to moderate strength of evidence 3, 7

Cross-Reactivity Considerations

  • The Journal of Allergy and Clinical Immunology notes a potential cross-reactivity between penicillins and cephalosporins due to shared structural components, with a risk of cross-reactivity in patients with a history of penicillin allergy 5
  • Patients with a history of penicillin allergy have approximately 2-4.8% risk of cross-reactivity with cephalosporins, as reported by the Journal of Allergy and Clinical Immunology, with a high strength of evidence 5
  • Amoxicillin and cephalexin share identical R1 side chains, which increases the risk of cross-reactivity between these specific agents, according to the Journal of Allergy and Clinical Immunology, with a moderate strength of evidence 5